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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to 
decision makers which, if relevant to them, they should go to before making decisions.   
 
Indirect impact of COVID-19 
Publication 
date 
Title/URL Journal/Article 
type 
Summary 
11.05.2020 Potential 
effects of 
disruption to 
HIV 
programmes in 
sub-Saharan 
Africa caused 
by COVID-19: 
results from 
multiple 
mathematical 
models 
Preprint (not 
peer-reviewed) 
 Five well-described models of HIV 
epidemics were each used to 
predict the potential effect of the 
COVID-19 epidemic on disruption 
to HIV prevention and treatment 
services on HIV-related deaths and 
new infections in sub-Saharan 
Africa over a one and 5 year period 
 A six month disruption of 
antiretroviral therapy could lead to 
more than 500,000 extra deaths 
from AIDS-related illnesses, 
including from TB, in sub-Saharan 
Africa in 2020-21. Shorter 
disruptions of three months would 
still see a significant impact on HIV 
deaths 
 Sporadic adherence to treatment 
risks spread of HIV drug resistance 
 Gains made in preventing mother-
to-child transmission of HIV could 
be reversed, with new HIV 
infections among children up by as 
much as 104% 
 A focus must remain on the supply 
of ARVs for people with HIV to 
2 
avoid additional HIV-related deaths 
and provision of other essential 
prevention measures to prevent any 
increase in HIV incidence 
Therapeutics 
Publication 
date 
Title/URL Journal/Article 
type 
Summary 
08.05.2020 Triple 
combination of 
interferon 
beta-1b, 
lopinavir-
ritonavir, and 
ribavirin in the 
treatment of 
patients 
admitted to 
hospital with 
COVID-19: an 
open-label, 
randomised 
phase 2 trial  
The Lancet | 
Article 
 This study showed that early 
treatment with triple antiviral therapy 
interferon beta-1b, lopinavir-ritonavir 
and ribavirin, compared with single 
antiviral therapy lopinavir-ritonavir, 
was safe and highly effective in 
shortening the duration of virus 
shedding, decreasing cytokine 
responses, alleviating symptoms, 
and facilitating the discharge of 
patients with mild to moderate 
COVID-19 
Guidelines, Statements & Tools 
Publication 
Date 
Title/URL Source   Summary 
10.05.2020 Considerations for 
public health and 
social measures in 
the workplace in the 
context of COVID-19 
WHO 
 Annex to Considerations in 
adjusting public health and social 
measures in the workplace in the 
context of COVID-19 
10.05.2020 Considerations for 
school-related public 
health measures in 
the context of 
COVID-19 
WHO 
 Annex to Considerations for 
school-related public health and 
social measures in the context of 
COVID-19 
3 
May 2020 Interim Guidance: 
Public health and 
social measures for 
COVID-19 
preparedness and 
response in low 
capacity and 
humanitarian 
settings version 1 
ICRC, IFRC, 
IOM, NRC, 
UNICEF, UN-
HABITAT, 
UNHCR, WHO 
in consultation 
with IASC 
members 
 This interim guidance outlines 
how to adapt to COVID-19 
prevention and response 
measures for use in low capacity 
and humanitarian settings 
07.05.2020 Global Humanitarian 
Response Plan for 
COVID-19: May 
Update 
UN OCHA 
 The humanitarian system is 
preparing for a sharp rise in 
conflict, food insecurity and 
poverty as a result of the C19 
pandemic 
 An increase in measles, malaria, 
cholera and other diseases are 
expected as vaccination 
programmes are put on hold, 
weak health systems are unable 
to cope and  supply chains are 
disrupted 
 The updated $6.7 billion global 
HRP is based on extensive in-
country consultations and reflects 
real-time needs 
 It brings together appeals from 
WHO and other UN humanitarian 
agencies shaped by NGOs and 
NGO consortia, through which 
they can access funding through 
it 
 The Plan provides help and 
protection that prioritise the most 
vulnerable in society in 63 LMICs 
and includes programmes that 
respond to the projected rapid 
growth in food insecurity 
05.05.2020 Community-based 
health care, including 
outreach and 
campaigns, in the 
context of the 
COVID-19 pandemic 
WHO & 
UNICEF | 
Interim 
Guidance 
 Discusses the specific role of 
community-based healthcare in 
the pandemic context and 
outlines adaptations needed to 
keep people safe, maintain 
continuity of essential services 
and ensure an effective response 
to C19 
May 2020 COVID-19: What are 
prisons a particular 
risk, and what can be 
done to mitigate this? 
SSHAP | Brief 
 Includes practical considerations 
to mitigate risks associated with 
an outbreak of C19 in prisons in 
LMICs 
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April 2020 Considerations and 
principles for 
shielding people at 
high risk of severe 
outcomes from 
COVID-19 
SSHAP | Brief 
 Considers the rationale for 
shielding individuals at high risk of 
severe disease or death from C19 
in LMICs 
 Provides overview of approaches 
to shielding, including who to 
shield, and the likely challenges 
and ways to mitigate these 
challengeslancet 
05.05.2020 LSHTM COVID-19 
Transmission Model 
(version 1) 
CMMID 
Repository 
 Simulate C19 epidemics in 152 
countries, and see how school 
closures, social distancing, 
elderly shielding, self-isolation 
and lockdowns may impact 
cases, hospitalisations and 
deaths. Designed for educational 
purposes not medical or policy 
advice. 
04.05.2020 Community 
participation is 
crucial in a pandemic 
The Lancet | 
Comment 
 Includes a panel of steps to 
community participation in the 
C19 response 
01.05.2020 Statement on the 
third meeting of the 
International Health 
Regulations (2005) 
Emergency 
Committee regarding 
the outbreak of 
coronavirus disease 
(COVID-19) 
WHO | 
Statement 
 Statement from the third meeting 
(teleconference) of the expanded 
Emergency Committee on 30 
April 2020 convened by the WHO 
DG under the IHR (2005) 
regarding CoVID-19 
30.04.2020 COVID-19 and the 
Rights of Persons 
with Disabilities: 
Guidance 
UN Human 
Rights 
  
28.04.2020 COVI-PREG CHUV 
 International COVID-19 and 
Pregnancy   Registry 
28.04.2020 Accessibility 
Campaign – COVID-
19 
International 
Disability 
Alliance 
 Call for PH information and 
communications around COVID-
19 to be fully accessible 
24.04.2020 Handwashing 
compendium for low 
resource settings: a 
IDS Sanitation 
Learning Hub 
  
5 
living document 
(edition 1) 
23.04.2020 Practical 
recommendations for 
the management of 
diabetes in patients 
with COVID-19 
The Lancet 
Diabetes & 
Endocrinology 
| Personal view 
 Practical recommendations for 
the management of diabetes in 
patients with C19, authored by an 
internal panel of experts in the 
fields of diabetes and 
endocrinology 
Ongoing WHO Country & 
Technical Guidance 
WHO   
Ongoing Rapid guidelines and 
evidence summaries 
NICE   
Ongoing Inter-Agency 
Standing Committee 
(IASC) 
IASC   
Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | Article type Author(s) 
May 2020 Harnessing behavioural science in 
public health campaigns to maintain 
‘social distancing’ in response to the 
COVID-19 pandemic: key principles 
J Epidemiol 
Community Health 
Chris Bonell et al. 
08.05.2020 Interferon beta-1b for COVID-19 The Lancet | Comment Sarah Shalhoub 
08.05.2020 Sharpening the global focus on 
ethnicity and race in the time of 
COVID-19 
The Lancet | Comment Neeraj Bhala et al. 
08.05.2020 COVID-19: a public health approach 
to manage domestic violence is 
needed 
The Lancet Public 
Health | 
Correspondence 
Joht Singh 
Chandan et al.  
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08.05.2020 Sex and gender differences in 
health: what the COVID-19 
pandemic can teach us 
Annals of Internal 
Medicine | Ideas and 
Opinions 
Primavera A. 
Spagnolo et al. 
08.05.2020 Sexual Health in the SARS-CoV-2 
Era 
Annals of Internal 
Medicine | Ideas and 
Opinions 
Jack L. Turban et 
al. 
07.05.2020 Access to lifesaving medical 
resources for African countries: 
COVID-19 testing and response, 
ethics and politics 
The Lancet | Viewpoint Matthew M 
Kavanagh et al. 
08.0.2020 COVID-19: How do you self-isolate 
in a refugee camp? 
Int J Public Health | 
Letter 
Emmanuel Raju 
and Sonja Ayeb-
Karlsson 
April 2020 Considerations and principles for 
shielding people at high risk of 
severe outcomes from COVID-19 
SSHAP | Briefing N Butler & Olivia 
Tulloch 
06.05.2020 Coronavirus: share lesson on lifting 
lockdowns 
Nature | Editorial 
 
07.05.2020 The equitable distribution of COVID-
19 therapeutics and vaccines 
JAMA | Viewpoint Thomas j. Bollyky, 
Lawrence O. 
Gostin & Margaret 
A. Hamburg 
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Online learning & events 
Date Title/URL Online 
learning/event 
Duration Lead 
7-28 May 
2020 
Virtual Evidence 
Weeks 
5 sessions 1h 30 International Initiative 
for Impact Evaluation 
(3ie) 
Tuesdays at 
1700 CEST 
(Geneva 
time) & 
Thursdays 
0830 CEST 
(Geneva 
time) 
COVID-19 Open 
online brief with Dr 
David Nabarro 
Event 1h 4SD 
11 
30.04.2020 Professor Chris 
Whitty’s Gresham 
lecture on COVID-19 
Event 1h 20 Gresham College 
Available 
now 
Emerging respiratory 
viruses, including 
COVID-19: methods 
for detection, 
prevention, response 
and control 
Online learning 3 hours WHO 
Available 
now 
Responding to 
COVID-19: Real-time 
training for the 
coronavirus disease 
outbreak 
Online learning Multiple 
self-paced 
course 
WHO 
25 May 
2020 
COVID-19: Tackling 
the Novel 
Coronavirus 
Online learning 3 weeks | 4 
hours 
weekly 
study 
FutureLearn 
LSHTM/UK PHRST 
Available 
online now 
without 
mentors. 
Updated 
version will 
commence 
early June 
2020 
COVID-19 
Diagnostics and 
Testing 
Online learning 3 weeks | 3 
hours 
weekly 
study 
FutureLearn 
FIND/LSHTM/ASLM 
6 April 2020 COVID-19 Critical 
Care: Understanding 
and Application 
Online learning 5 weeks | 1 
hour 
weekly 
study 
FutureLearn University 
of Edinburgh & Royal 
College of Physicians 
of Edinburgh  
Available 
now 
COVID-19 supporting 
online courses 
Online learning Multiple 
self-paced 
course 
BMJ Learning 
 
12 
Suggested citation 
Millington, K.A. (2020). COVID-19 Health Evidence Summary No.35. K4D Evidence Summary. 
Brighton, UK: Institute of Development Studies. 
Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa”) OR (“equity” OR “equities”) OR (“poverty”), restricted to 
articles published in the previous 2 to 3 days, in English. This is complemented by a search of the homepage of 
the following high-impact global health journals: The Lancet journals, New England Journal of Medicine, Nature, 
JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ Global Health, the PLoS journals and a Twitter 
search of their Twitter pages. A search also of preprints from bioRxiv and medRxiv. Please note that papers that 
have not been peer-reviewed are highlighted in red. All primary research papers that relate to the primary and 
secondary impacts of the COVID-19 response in LMICs, and disease control and health system responses are 
included. Articles related to tackling the secondary impacts on other sectors are not included. Additional 
commentaries, opinions, and commissioned pieces are selected based on relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
About this report 
This daily COVID-19 health evidence summary (HES) is based on 3 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before 
making decisions. The HES are not intended to replace medical or professional advice and the researcher or the 
K4D consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES 
alone. K4D services are provided by a consortium of leading organisations working in international development, 
led by the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds 
Nuffield Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), 
University of Birmingham International Development Department (IDD) and the University of Manchester 
Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. 
It is licensed for non-commercial purposes only. K4D cannot be held responsible for 
errors, omissions or any consequences arising from the use of information contained in 
this health evidence summary. Any views and opinions expressed do not necessarily 
reflect those of DFID, K4D or any other contributing organisation.  
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